Literature DB >> 28294134

Influence of Familial Risk for Depression on Cortico-Limbic Connectivity During Implicit Emotional Processing.

Carolin Wackerhagen1, Torsten Wüstenberg1, Sebastian Mohnke1, Susanne Erk1, Ilya M Veer1, Johann D Kruschwitz1, Maria Garbusow1, Lydia Romund1, Kristina Otto2, Janina I Schweiger2, Heike Tost2, Andreas Heinz1, Andreas Meyer-Lindenberg2, Henrik Walter1, Nina Romanczuk-Seiferth1.   

Abstract

Imbalances in cortico-limbic activity and functional connectivity (FC) supposedly underlie biased emotional processing and present putative intermediate phenotypes (IPs) for major depressive disorder (MDD). To prove the validity of these IPs, we assessed them in familial risk. In 70 healthy first-degree relatives of MDD patients and 70 controls, brain activity and seed-based amygdala FC were assessed during an implicit emotional processing task for fMRI containing angry and fearful faces. Using the generalized psychophysiological interaction approach, amygdala FC was assessed (a) across conditions to provide comparable data to previous studies and (b) compared between conditions to elucidate its implications for emotional processing. Associations of amygdala FC with self-reported negative affect were explored post hoc. Groups did not differ in brain activation. In relatives, amygdala FC across conditions was decreased with superior and medial frontal gyrus (SFG, MFG) and increased with subgenual and perigenual anterior cingulate cortex (sgACC, pgACC). NA was inversely correlated with amygdala FC with MFG, pgACC and their interaction in relatives. Relatives showed aberrant condition-dependent modulations of amygdala FC with visual cortex, thalamus and orbitofrontal cortex. Our results do not support imbalanced cortico-limbic activity as IP for MDD. Diminished amygdala-dorsomedial prefrontal FC in relatives might indicate insufficient regulatory capacity, which appears to be compensated by ventromedial prefrontal regions. Differential task-dependent modulations of amygdala FC are discussed as a stronger involvement of automatic instead of voluntary emotional processing pathways. Reliability and etiological implications of these results should be investigated in future studies including longitudinal designs and patient-risk-control comparisons.

Entities:  

Mesh:

Year:  2017        PMID: 28294134      PMCID: PMC5518910          DOI: 10.1038/npp.2017.59

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  46 in total

1.  Altered inhibition of negative emotions in subjects at family risk of major depressive disorder.

Authors:  Danuta M Lisiecka; Angela Carballedo; Andrew J Fagan; Gerald Connolly; James Meaney; Thomas Frodl
Journal:  J Psychiatr Res       Date:  2011-11-10       Impact factor: 4.791

Review 2.  Neural mechanisms of the cognitive model of depression.

Authors:  Seth G Disner; Christopher G Beevers; Emily A P Haigh; Aaron T Beck
Journal:  Nat Rev Neurosci       Date:  2011-07-06       Impact factor: 34.870

3.  The Social Readjustment Rating Scale.

Authors:  T H Holmes; R H Rahe
Journal:  J Psychosom Res       Date:  1967-08       Impact factor: 3.006

4.  A generalized form of context-dependent psychophysiological interactions (gPPI): a comparison to standard approaches.

Authors:  Donald G McLaren; Michele L Ries; Guofan Xu; Sterling C Johnson
Journal:  Neuroimage       Date:  2012-03-30       Impact factor: 6.556

5.  Neural correlates of automatic mood regulation in girls at high risk for depression.

Authors:  Jutta Joormann; Rebecca E Cooney; Melissa L Henry; Ian H Gotlib
Journal:  J Abnorm Psychol       Date:  2011-09-05

6.  Amygdala and nucleus accumbens activation to emotional facial expressions in children and adolescents at risk for major depression.

Authors:  Christopher S Monk; Rachel G Klein; Eva H Telzer; Elizabeth A Schroth; Salvatore Mannuzza; John L Moulton; Mary Guardino; Carrie L Masten; Erin B McClure-Tone; Stephen Fromm; R James Blair; Daniel S Pine; Monique Ernst
Journal:  Am J Psychiatry       Date:  2007-11-06       Impact factor: 18.112

7.  Volition diminishes genetically mediated amygdala hyperreactivity.

Authors:  Dina M Schardt; Susanne Erk; Corinna Nüsser; Markus M Nöthen; Sven Cichon; Marcella Rietschel; Jens Treutlein; Thomas Goschke; Henrik Walter
Journal:  Neuroimage       Date:  2009-12-05       Impact factor: 6.556

8.  5-HTT genotype effect on prefrontal-amygdala coupling differs between major depression and controls.

Authors:  Eva Friedel; Florian Schlagenhauf; Philipp Sterzer; Soyoung Q Park; Felix Bermpohl; Andreas Ströhle; Meline Stoy; Imke Puls; Claudia Hägele; Jana Wrase; Christian Büchel; Andreas Heinz
Journal:  Psychopharmacology (Berl)       Date:  2009-04-23       Impact factor: 4.530

9.  Serotonin transporter genetic variation and the response of the human amygdala.

Authors:  Ahmad R Hariri; Venkata S Mattay; Alessandro Tessitore; Bhaskar Kolachana; Francesco Fera; David Goldman; Michael F Egan; Daniel R Weinberger
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

10.  Abnormal left-sided orbitomedial prefrontal cortical-amygdala connectivity during happy and fear face processing: a potential neural mechanism of female MDD.

Authors:  Jorge Renner Cardoso de Almeida; Dina Michaela Kronhaus; Etienne L Sibille; Scott A Langenecker; Amelia Versace; Edmund James Labarbara; Mary Louise Phillips
Journal:  Front Psychiatry       Date:  2011-12-08       Impact factor: 4.157

View more
  9 in total

1.  Brain areas associated with resilience to depression in high-risk young women.

Authors:  Birce Begum Burhanoglu; Gulsah Dinçer; Alpaslan Yilmaz; Ozgun Ozalay; Ozgul Uslu; Esmin Unaran; Omer Kitis; Ali Saffet Gonul
Journal:  Brain Struct Funct       Date:  2021-01-17       Impact factor: 3.270

2.  Using Cognitive Neuroscience to Improve Mental Health Treatment: A Comprehensive Review.

Authors:  Jessica A Wojtalik; Shaun M Eack; Matthew J Smith; Matcheri S Keshavan
Journal:  J Soc Social Work Res       Date:  2018-04-27

3.  Experiences of Discrimination Are Associated With Greater Resting Amygdala Activity and Functional Connectivity.

Authors:  Uraina S Clark; Evan R Miller; Rachal R Hegde
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-12-08

4.  Neural response to emotional faces in monozygotic twins: association with familial risk of affective disorders

Authors:  Iselin Meluken; Ninja Ottesen; Catherine Harmer; Julian Macoveanu; Hartwig Siebner; Lars Kessing; Maj Vinberg; Kamilla Miskowiak
Journal:  J Psychiatry Neurosci       Date:  2019-07-01       Impact factor: 6.186

5.  Associating Flexible Regulation of Emotional Expression With Psychopathological Symptoms.

Authors:  Gabriel Gonzalez-Escamilla; Denise Dörfel; Miriam Becke; Janina Trefz; George A Bonanno; Sergiu Groppa
Journal:  Front Behav Neurosci       Date:  2022-06-27       Impact factor: 3.617

6.  Neural correlates of RDoC-specific cognitive processes in a high-functional autistic patient: a statistically validated case report.

Authors:  Torsten Wüstenberg; Andreas Heinz; Laura S Daedelow; Anne Beck; Lydia Romund; Lea Mascarell-Maricic; Isabel Dziobek; Nina Romanczuk-Seiferth
Journal:  J Neural Transm (Vienna)       Date:  2021-05-18       Impact factor: 3.575

7.  Multimodal brain imaging connectivity analyses of emotional and motivational deficits in depression among women.

Authors:  Gabriel Robert; Elise Bannier; Magali Comte; Lea Domain; Isabelle Corouge; Thibaut Dondaine; Jean-Marie Batail; Jean-Christophe Ferre; Eric Fakra; Dominique Drapier
Journal:  J Psychiatry Neurosci       Date:  2021-04-12       Impact factor: 6.186

Review 8.  Prefrontal cortex and depression.

Authors:  Diego A Pizzagalli; Angela C Roberts
Journal:  Neuropsychopharmacology       Date:  2021-08-02       Impact factor: 7.853

9.  An enriched granger causal model allowing variable static anatomical constraints.

Authors:  Kun Bi; Guoping Luo; Shui Tian; Siqi Zhang; Xiaoxue Liu; Qiang Wang; Qing Lu; Zhijian Yao
Journal:  Neuroimage Clin       Date:  2018-11-05       Impact factor: 4.881

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.